NOT KNOWN DETAILS ABOUT HEMGENIX

Range of suitable clients: CDEC discussed the uncertainty in the number of sufferers with moderately extreme to intense hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some people who are categorised as having gentle or reasonable disorder could have a critical bleeding phenotyp